Trial
NCT00303719
Allogeneic Bone Marrow Transplantation Using Less Intensive Therapy
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Masonic Cancer Center, University of Minnesota
Collaborators
—
Condition
Kidney Cancer
Intervention
anti-thymocyte globulin
Why stopped
IRB Study Closure
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-05-12